A 32P-postlabeling procedure for identifying and quantifying hydrophobic DNA adducts was developed ( 
Introduction
Interspecies and interindividual variability in response to chemical carcinogens may be attributable in part to differences in the dose delivered to the target site. Many carcinogens bind covalently to DNA, and this DNA modification is thought to be a key initial event in mutagenesis and carcinogenesis. Thus, carcinogen-DNA adducts may be biologically important markers of the delivered dose.
Postlabeling assays are useful for quantifying DNA adducts formed in vivo. Recently, a version ofthe "P-postlabeling procedure in which high-performance liquid chromatography (HPLC), instead of thin-layer chromatography, is used for separation of labeled adducts was described (1) . This method was used to detect and quantify fluoranthene (FA) adducts in the rat (2) . FA, like other polycyclic aromatic hydrocarbons (PAH), is generally produced as a result of incomplete pyrolysis oforganic material, resulting in widespread environmental exposure to complex mixtures of PAH. Therefore, application of the HPLC-32P-posflabeling method in studies for monitoring human exposure to PAH requires chromatographic separation and quantitative recovery of multiple 32P-labeled PAH adducts in one sample. In recent studies, the HPLC 32P-postlabeling procedure has been extended for the detection ofmultiple PAH adducts. We chose to establish detection methods for benzo[a]pyrene (BaP), chrysene (CH) and benz(a)anthracene (BA) diol epoxide (DE) adducts, because these adducts, as well as others, cross-react in a widely applied immunoassay (3) (4) (5) . Thus, the postlabeling method described herein would be complementary to that immunosssay.
Methods and Results
The HPLC-32P-Postlabeling Procedure for FA Adducts
The HPLC-32P-postlabeling method first developed for quantative analysis of FA adducts (1) is outlined in Figure 1 (Fig. 2) by the HPLC-32P-postlabeling method exactly as previously described (1) i.e., with nuclease P1 pretreatment for 15 min and nuclease P1 post-treatment for [16] [17] [18] hr, were unsuccessful; "P-labeled adducts were not detected (data not shown). Because the cornerstone ofthis method is the balance between adduct resistance to briefnuclease P1-mediated dephosphorylation and adduct suceptibility to extensive nuclease P1-mediated dephosphorylation, the sensitivity ofeach of these PAH diol epoxide adducts to nuclease P1-mediated dephosphorylation was investigated.
Chromatographic profiles ofa "P-labeled adducts and the appropriate ultraviolet markers are shown in Figure 3 . In each case, a major 32p peak co-eluted with the appropriate authentic nucleotide 5 '-monophosphate adduct. No qualitative difference was observed in any ofthe chromatographic profiles associated with either nuclease P1 pretreatment or the duration of nuclease P1 post-treatment (data not shown).
The effect of nuclease P1 pretreatment on recovery of 32p_ labeled adducts was determined. The improvement in recovery of BPDE, BADE, and CHDE adducts by inclusion of a 10-min nuclease P1 pretreatment step is indicated recovery improved by at least 6-fold as much as 20-fold (BPDE). Analyses for 32p Thus, to eliminate the residual nucleotides as substrates in the labeling reaction, the 3 '-phosphate moiety is selectively removed from unmodified nucleotides by a brief (15- 
